Mammalian mRNA splice-isoform selection is tightly controlled

Genetics

Volumn 175, Issue 3, 2007, Pages 1079-1087

  Chisa, Jennifer L ^a   Burke, David T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC VARIABILITY; MALE; MAMMAL; MOUSE; NONHUMAN; PHENOTYPE; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TRANS SPLICING; UPREGULATION;

AGE FACTORS; ALTERNATIVE SPLICING; ANIMALS; CROSSES, GENETIC; FEMALE; HOMEOSTASIS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SELECTION (GENETICS); STATISTICS, NONPARAMETRIC; VARIATION (GENETICS);

EUKARYOTA; MAMMALIA; MUS;

EID: 34249008980     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.106.066183     Document Type: Article

References (49)

1. BAHAR, R., C. H. HARTMANN, K. A. RODRIGUEZ, A. D. DENNY, R. A. BUSUTTIL et al., 2006 Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature 441: 1011-1014.
2. BARBAUX, S., P. NIAUDET, M. C. GUBLER, J. P. GRUNFELD, F. JAUBERT et al., 1997 Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17: 467-470.
3. BAUDRY, D., M. HAMELIN, M. O. CABANIS, J. C. FOURNET, M. F. TOURNADE et al., 2000 WT1 splicing alterations in Wilms' tumors. Clin. Cancer Res. 6: 3957-3965.
4. BECSKEI, A., and L. SERRANO, 2000 Engineering stability in gene networks by autoregulation. Nature 405: 590-593.
5. BERTRAM, L., M. HILTUNEN, M. PARKINSON, M. INGELSSON, C. LANGE et al., 2005 Family-based association between Alzheimer's disease and variants in UBQLN1. N. Engl. J. Med. 352: 884-894.
6. BLAND, J. M., and D. G. ALTMAN, 1986 Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
7. BRAUN, E., and N. BRENNER, 2004 Transient responses and adaptation to steady state in a eukaryotic gene regulation system. Physiol. Biol. 1: 67-76.
8. CAO, R., and Y. ZHANG, 2004 The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14: 155-164.
9. CARMELIET, P., V. FERREIRA, G. BREIER, S. POLLEFEYT, L. KIECKENS et al., 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
10. DAVIS, C. A., L. GRATE, M. SPINGOLA and M. ARES, JR., 2000 Test of intron predictions reveals novel splice sites, alternatively spliced mRNAs and new introns in meiotically regulated genes of yeast. Nucleic Acids Res. 28: 1700-1706.
11. GRETARSDOTTIR, S., G. THORLEIFSSON, S. T. REYNISDOTTIR, A. MANOLESCU, S. JONSDOTTIR et al., 2003 The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35: 131-138.
12. GUO, J. K., A. L. MENKE, M. C. GUBLER, A. R. CLARKE, D. HARRISON et al., 2002 WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum. Mol. Genet. 11: 651-659.
13. HAGENDORF, A., J. W. KOPER, F. H. DE JONG, A. O. BRINKMANN, S. W. J. LAMBERTS et al., 2005 Expression of the human glucocorticoid receptor splice variants a, b, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism. J. Clin. Endocrinol. Metab. 90: 6237-6243.
14. HAMMES, A., J. K. GUO, G. LUTSCH, J. R. LEHESTE, D. LANDROCK et al., 2001 Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106: 319-329.
15. HARPER, J. M., A. T. GALECKI, D. T. BURKE, S. L. PINKOSKY and R. A. MILLER, 2003 Quantitative trait loci for insulin-like growth factor-I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice. Physiol. Genomics 15: 44-51.
16. IDEKER, T., V. THORSSON, J. A. RANISH, R. CHRISTMAS, J. Buhler et al., 2001 Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929-934.
17. JACKSON, A. U., A. FORNES, A. GALECKI, R. A. MILLER and D. T. BURKE, 1999 Multiple-trait quantitative trait loci analysis using a large mouse sibship. Genetics 151: 785-789.
18. JACKSON, A. U., A. T. GALECKI, D. T. BURKE and R. A. MILLER, 2003 Genetic polymorphisms in mouse genes regulating age-sensitive and age-stable T cell subsets in mice. Genes Immun. 4: 30-39.
19. JOHNSON, J. M., J. CASTLE, P. GARRETT- ENGELE, Z. KAN, P. M. LOERCH et al., 2003 Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141-2144.
20. KIRSCHNER, M., and J. GERHART, 1998 Perspective: evolvability. Proc. Natl. Acad. Sci. USA 95: 8420-8427.
21. KLAMT, B., A. KOZIELL, F. POULAT, P. WIEACKER, P. SCAMBLER et al., 1998 Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum. Mol. Genet. 7: 709-714.
22. LAITINEN, T., A. POLVI, P. RYDMAN, J. VENDELIN, V. PULKKINEN et al., 2004 Characterization of a common susceptibility locus for asthma-related traits. Science 304: 300-304.
23. LI, F., T. LONG, Y. LU, Q. OUYANG and C. TANG, 2004 The yeast cell-cycle network is robustly designed. Proc. Natl. Acad. Sci. USA 101: 4781-4786.
24. LI, J., G. NING and S. A. DUNCAN, 2000 Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 14: 464-474.
25. LINDBLAD-TOH, K., E. WINCHESTER, M. J. DALY, D. G. WANG, J. N. HIRSCHHORN et al., 2000 Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat. Genet. 24: 381-386.
26. LIPMAN, R. D., A. T. GALECKI, D. T. BURKE and R. A. MILLER, 2004 Genetic loci that influence cause of death in a heterogeneous mouse stock. J. Gerontol. A Biol. Sci. Med. Sci. 59: 977-983.
27. LITTLE, J. W., D. P. SHEPLEY and D. W. WERT, 1999 Robustness of a gene regulatory circuit. EMBO J. 18: 4299-4307.
28. MACALUSO, M., G. RUSSO, C. CINTI, V. BAZAN, N. GEBBIA et al., 2002 Ras family genes: an interesting link between cell cycle and cancer. J. Cell. Physiol. 192: 125-130.
29. MAES, C., I. STOCKMANS, K. MOERMANS, R. VAN LOOVEREN, N. SMETS et al., 2004 Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 113: 188-199.
30. MANIATIS, T., and B. TASIC, 2002 Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418: 236-243.
31. MARDEN, J. H., 2006 Quantitative and evolutionary biology of alternative splicing: how changing the mix of alternative transcripts affects phenotypic plasticity and reaction norms. Heredity (in press).
32. MILLER, R. A., J. M. HARPER, A. T. GALECKI and D. T. BURKE, 2002 Big mice die young: early life body weight predicts longevity in genetically heterogeneous mice. Aging Cell 1: 22-29.
33. MINN, A. J., L. H. BOISE and C. B. THOMPSON, 1996 Bcl-x(S) anatagonizes the protective effects of Bcl-x(L). J. Biol. Chem. 271: 6306-6312.
34. NAIR, S. V., H. DEL VALLE, P. S. GROSS, D. P. TERWILLIGER and L. C. SMITH, 2005 Macroarray analysis of coelomocyte gene expression in response to LPS in the sea urchin. Identification of unexpected immune diversity in an invertebrate. Physiol. Genomics 22: 33-47.
35. Nijhout, H. F., 2002 The nature of robustness in development. BioEssays 24: 553-563.
36. PAN, Q., O. SHAI, C. MISQUITTA, W. ZHANG, A. L. SALTZMAN et al., 2004 Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Mol. Cell 16: 929-941.
37. RUTHERFORD, R. L., and S. LINDQUIST, 1998 Hsp90 as a capacitor for morphological evolution. Nature 396: 336-342.
38. SAVAGEAU, M. A., 1974 Comparison of the classical and autogenous system of regulation in inducible operons. Nature 252: 546-549.
39. SCHMUCKER, D., J. C. CLEMENS, H. SHU, C. A. WORBY, J. XIAO et al., 2000 Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell 101: 671-684.
40. SHAROV, A. A., D. B. DUDEKULA and M. S. KO, 2005 Genome-wide assembly and analysis of alternative transcripts in mouse. Genome Res. 15: 748-754.
41. SLADEK, F. M., M. D. RUSE, JR., L. NEPOMUCENO, S.-M. HUANG and M. R. STALLCUP, 1999 Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4 alpha-1. Mol. Cell. Biol. 19: 6509-6522.
42. STAMM, S., S. BEN-ARI, I. RAFALSKA, Y. TANG, Z. ZHANG et al., 2005 Function of alternative splicing. Gene 344: 1-20.
43. UEDA, H., J. M. HOWSON, L. ESPOSITO, J. HEWARD, H. SNOOK et al., 2003 Association of the T cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
44. VOICE, J. K., R. L. KLEMKE, A. LE and J. H. JACKSON, 1999 Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274: 17164-17170.
45. VOLKMAN, S. K., A. T. GALECKI, D. T. BURKE, M. R. PACZA, M. R. MOALLI et al., 2003 Quantitative trait loci for femoral size and shape in a genetically heterogeneous mouse population. J. Bone Miner. Res. 18: 1497-1505.
46. XIE, H., W. Y. ZHU, A. WASSERMAN, V. GREBINSKIY, A. OLSON et al., 2002 Computational analysis of alternative splicing using EST tissue information. Genomics 80: 326-330.
47. XU, Q., B. MODREK and C. LEE, 2002 Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res. 30: 3754-3766.
48. YANG, G., S.-C. HUANG, J. Y. WU and E. J. BENZ, JR., 2005 An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer. Blood 105: 2146-2153.
49. ZELZER, E., W. MCLEAN, Y.-S. NG, N. FUKAI, A. M. REGINATO et al., 2002 Skeletal defects in VEGF120/120 mice reveal multiple roles for VEGF in skeletogenesis. Development 129: 1893-1904.